Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Acute myeloid leukaemia+1

Not yet recruiting

Registered drugNo placebo

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Cytarabine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Phase 1b Study of MK-0482 in Adults with Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mk-0482

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Pharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Aldesleukin

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Venetoclax and Decitabine for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Eligible for Stem Cell Transplant

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Decitabine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Pentaglobin for Treating Fever in Acute Leukemia or Stem Cell Transplant Patients with Resistant Bacteria

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Immunoglobulin A

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drug

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

Registered drugNo placebo

France

Participants:0–17 years
Substances:Busulfan

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 7

132 trials match your criteria

Acute myeloid leukaemia+1

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Acute myeloid leukaemia+1

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Acute myeloid leukaemia+1

Phase 1b Study of MK-0482 in Adults with Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Acute myeloid leukaemia

Pharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia

Acute myeloid leukaemia

Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Acute myeloid leukaemia+1

Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

Acute myeloid leukaemia

Study of Venetoclax and Decitabine for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Eligible for Stem Cell Transplant

Acute myeloid leukaemia

Study on Pentaglobin for Treating Fever in Acute Leukemia or Stem Cell Transplant Patients with Resistant Bacteria

Acute myeloid leukaemia

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Acute myeloid leukaemia

Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

Acute myeloid leukaemia

Study on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations

Acute myeloid leukaemia

Study on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.